Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flavio Caprioli

Showing results (141-150 of 176) with videos related to

Pageof 18
Sort By:
European Journal of Gastroenterology & Hepatology|April 28, 2023
Safety, hesitancy of coronavirus disease 2019 vaccination and pandemic burden in patients with inflammatory bowel disease: data of a national study (ESCAPE-IBD)Mariabeatrice Principi, Fabio Salvatore Macaluso, Alessia Todeschini, et al.
The New England Journal of Medicine|March 19, 2015
Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's diseaseGiovanni Monteleone, Markus F Neurath, Sandro Ardizzone, et al.
Mucosal Immunology|April 2, 2023
iNKT cell-neutrophil crosstalk promotes colorectal cancer pathogenesisGeorgia Lattanzi, Francesco Strati, Angélica Díaz-Basabe, et al.
Journal of Crohn'S & Colitis|December 23, 2025
Learning Curve in Intestinal Ultrasound: Advancing from Basic Skills to Advanced Competencies-Insights from the IUS IG-IBD Master ProgramCristina Bezzio, Luisa Bertin, Simone Saibeni, et al.
Alimentary Pharmacology & Therapeutics|July 25, 2022
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE studyDaniela Pugliese, Giuseppe Privitera, Federica Crispino, et al.
Mucosal Immunology|December 11, 2025
Corrigendum to "iNKT cell-neutrophil crosstalk promotes colorectal cancer pathogenesis" [Mucosal Immunol. 16(3) (2023) 326-340Georgia Lattanzi, Francesco Strati, Angélica Díaz-Basabe, et al.
Autoimmunity Reviews|March 23, 2024
The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensusFabio Salvatore Macaluso, Flavio Caprioli, Laura Benedan, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 20, 2022
Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD studyFabio Salvatore Macaluso, Mariabeatrice Principi, Federica Facciotti, et al.
Journal of Gastroenterology and Hepatology|June 23, 2021
Lower incidence of COVID-19 in patients with inflammatory bowel disease treated with non-gut selective biologic therapySandro Ardizzone, Francesca Ferretti, Maria Camilla Monico, et al.
Journal of Crohn'S & Colitis|July 18, 2023
An Intestinal Th17 Subset is Associated with Inflammation in Crohn's Disease and Activated by Adherent-invasive Escherichia coliMoira Paroni, Gabriella Leccese, Valeria Ranzani, et al.
Pageof 18

Showing results (141-150 of 176) with videos related to

Sort By:
Pageof 18
European Journal of Gastroenterology & Hepatology|April 28, 2023
Safety, hesitancy of coronavirus disease 2019 vaccination and pandemic burden in patients with inflammatory bowel disease: data of a national study (ESCAPE-IBD)Mariabeatrice Principi, Fabio Salvatore Macaluso, Alessia Todeschini, et al.
The New England Journal of Medicine|March 19, 2015
Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's diseaseGiovanni Monteleone, Markus F Neurath, Sandro Ardizzone, et al.
Mucosal Immunology|April 2, 2023
iNKT cell-neutrophil crosstalk promotes colorectal cancer pathogenesisGeorgia Lattanzi, Francesco Strati, Angélica Díaz-Basabe, et al.
Journal of Crohn'S & Colitis|December 23, 2025
Learning Curve in Intestinal Ultrasound: Advancing from Basic Skills to Advanced Competencies-Insights from the IUS IG-IBD Master ProgramCristina Bezzio, Luisa Bertin, Simone Saibeni, et al.
Alimentary Pharmacology & Therapeutics|July 25, 2022
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE studyDaniela Pugliese, Giuseppe Privitera, Federica Crispino, et al.
Mucosal Immunology|December 11, 2025
Corrigendum to "iNKT cell-neutrophil crosstalk promotes colorectal cancer pathogenesis" [Mucosal Immunol. 16(3) (2023) 326-340Georgia Lattanzi, Francesco Strati, Angélica Díaz-Basabe, et al.
Autoimmunity Reviews|March 23, 2024
The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensusFabio Salvatore Macaluso, Flavio Caprioli, Laura Benedan, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 20, 2022
Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD studyFabio Salvatore Macaluso, Mariabeatrice Principi, Federica Facciotti, et al.
Journal of Gastroenterology and Hepatology|June 23, 2021
Lower incidence of COVID-19 in patients with inflammatory bowel disease treated with non-gut selective biologic therapySandro Ardizzone, Francesca Ferretti, Maria Camilla Monico, et al.
Journal of Crohn'S & Colitis|July 18, 2023
An Intestinal Th17 Subset is Associated with Inflammation in Crohn's Disease and Activated by Adherent-invasive Escherichia coliMoira Paroni, Gabriella Leccese, Valeria Ranzani, et al.
Pageof 18